Dermavant Announces FDA Acceptance for Filing of New Drug Application (NDA) for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis

LONG BEACH, Calif.& BASEL, Switzerland--(BUSINESS WIRE) August 10, 2021 --Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news